BHST - BioHarvest Sciences, Inc. Debt to Book Capitalization Ratio

The price evolution of BioHarvest Sciences (BHST) demonstrates the dynamics of an asset currently valued at 0.95. BioHarvest Sciences (BHST) dominates pricing through innovative Bio-Farming, creating pure plant cells without agrochemicals. Revenue is generated by supplying premium bioactive components for medicine and nutrition. The business's ecological focus relies on bioreactors, which radically reduce the consumption of water resources and land.

This ratio assesses the stability of the capital structure by comparing total debt obligations against the book value of assets to determine the level of leverage. By analyzing the trend of the debt-to-equity ratio, an investor can observe the balance between financial stability and investments in scaling the bioreactor capacities of BioHarvest Sciences (BHST), which enable the production of pure nutrients independently of external climatic factors.